We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Test Predicts Diabetes Risk in Early Pregnancy

By LabMedica International staff writers
Posted on 13 Jun 2013
Levels of a biomarker in a pregnant woman's blood can help physicians gauge her risk of developing gestational diabetes during the first trimester. More...


Gestational diabetes causes glucose levels in the bloodstream to be higher than normal and early diagnosis and treatment can help the woman manage the condition, because if left untreated there is an increased the risk of premature delivery.

Endocrinologists at Tokyo Women's Medical University (Japan) conducted a prospective cohort study of 716 pregnant women who first visited the hospital during their first trimester between 2010 and 2011. Plasma samples were obtained at the time of routine blood testing during the first trimester, at less than 14 weeks gestation. Blood glucose levels were determined.

Enzyme-linked immunosorbent assays (ELISA) were performed in duplicate to determine the levels of soluble (pro)renin receptor [s(P)RR] using commercially available kits (Immuno-Biological Laboratories Co.; Fujioka, Japan). The detection limit of the kit was 24 pg/mL, and inter- and intra-assay coefficients of variation were 7.5% and 5.5%, respectively.

Among the 716 participants, there were 44 (6.1%) women who had gestational diabetes mellitus (GDM) and 672 (93.9%) who did not. The team found that pregnant women with elevated s(P)RR levels were more likely to be diagnosed with gestational diabetes. Women who had the highest s(P)RR levels of above 34.2 ng/mL were 2.9 times more likely to develop gestational diabetes than women who had the lowest levels. All s(P)RR concentrations were above the level required for detection of 24 pg/mL and the mean s(P)RR of the entire cohort was 30.6 ± 9.5 ng/mL.

Atsuhiro Ichihara, MD, a senior author of the study said, “In addition to gestational diabetes, recent studies have found elevated s(P)RR levels are associated with the birth of larger babies and high blood pressure in late pregnancy. The evidence suggests the biomarker is important in the interaction between mother and fetus during pregnancy." The study was published on May 29, 2013, in the Journal of Clinical Endocrinology & Metabolism.

Related Links:
Tokyo Women's Medical University

Immuno-Biological Laboratories





Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.